D C Harrison. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adrenergic beta-Antagonists/adverse effectsAdrenergic beta-Antagonists/metabolismAdrenergic beta-Antagonists/pharmacologyAdrenergic beta-Antagonists/therapeutic useAlprenolol/pharmacologyAngina Pectoris/drug therapyAngina Pectoris/prevention & controlArrhythmias, Cardiac/drug therapyCardiovascular Diseases/drug therapyHumansHypertension/drug therapyHypertension/physiopathologyHyperthyroidism/drug therapyMetabolism/drug effectsMyocardial Infarction/drug therapyParasympathetic Nervous System/physiopathologyPropranolol/therapeutic useReceptors, Adrenergic/drug effectsRespiration/drug effectsStereoisomerism
Substances: See more » Adrenergic beta-AntagonistsReceptors, AdrenergicAlprenololPropranolol
Year: 1974 PMID: 4152164 DOI: 10.2165/00003495-197407010-00001
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546